MIRA

MIRA PHARMACEUTICALS, INC. MIRA

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$2.19M total
VANGUARD CAPITAL MANAGEMENT LLC
$712.0K+8.3%
Cross Staff Investments Inc
$340.2K0.0%
GEODE CAPITAL MANAGEMENT, LLC
$287.6K+4.5%
BlackRock, Inc.
$231.5K+117.7%
VANGUARD FIDUCIARY TRUST CO
$161.6K+0.7%
CAPTRUST FINANCIAL ADVISORS
$85.8KNew
NORTHERN TRUST CORP
$64.1K+0.1%
First American Bank
$56.8K0.0%
COMMONWEALTH EQUITY SERVICES, LLC
$50.3K+51.7%
STATE STREET CORP
$46.5K0.0%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC
$33.2K0.0%
FIFTH THIRD BANCORP
$18.9K0.0%
CITADEL ADVISORS LLC
$17.7KNew
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$17.6K-26.2%
Mariner, LLC
$15.6K0.0%
XTX Topco Ltd
$15.5K-56.4%
HRT FINANCIAL LP
$12.0KNew
CARY STREET PARTNERS FINANCIAL LLC
$9.5K0.0%
Federation des caisses Desjardins du Quebec
$7.6K0.0%
OSAIC HOLDINGS, INC.
$1.9K0.0%
UBS Group AG
$1.7K-72.6%
CITIGROUP INC
$1.1K-71.4%
Steward Partners Investment Advisory, LLC
$947-50.0%
Tower Research Capital LLC (TRC)
$489-89.6%
BARCLAYS PLC
$150New
See all 26 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/MIRA

Earnings Per Share

13fpro.ai/company/MIRA

Loading ratio trend…

MIRA insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About MIRA PHARMACEUTICALS, INC. (MIRA): stock profile, AI score and financials

MIRA PHARMACEUTICALS, INC. (MIRA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. MIRA is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of MIRA by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, Cross Staff Investments, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. MIRA trades on the Nasdaq exchange and files with the SEC under CIK 1904286. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MIRA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MIRA PHARMACEUTICALS, INC. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1904286 →